1-179551195-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM1PP2BP4_Moderate
The NM_014625.4(NPHS2):c.1130A>G(p.Lys377Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014625.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS2 | ENST00000367615.9 | c.1130A>G | p.Lys377Arg | missense_variant | Exon 8 of 8 | 1 | NM_014625.4 | ENSP00000356587.4 | ||
AXDND1 | ENST00000367618.8 | c.3032-3317T>C | intron_variant | Intron 25 of 25 | 1 | NM_144696.6 | ENSP00000356590.3 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152158Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000798 AC: 20AN: 250698 AF XY: 0.0000811 show subpopulations
GnomAD4 exome AF: 0.000140 AC: 204AN: 1461826Hom.: 0 Cov.: 37 AF XY: 0.000153 AC XY: 111AN XY: 727214 show subpopulations
GnomAD4 genome AF: 0.000145 AC: 22AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74324 show subpopulations
ClinVar
Submissions by phenotype
Nephrotic syndrome, type 2 Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces lysine with arginine at codon 377 of the NPHS2 protein (p.Lys377Arg). The lysine residue is weakly conserved and there is a small physicochemical difference between lysine and arginine. This variant is present in population databases (rs770990923, ExAC 0.009%). This variant has not been reported in the literature in individuals with NPHS2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at